MIR320E: MIR320E is a miRNA that has been studied in various contexts. It has been found to be positively correlated with interleukin ST-2 in follow-up measurements [PMC10136141]. MIR320E is one of the miRNAs that were selected for further analysis based on their availability and detectability [PMC10136141]. It has also been identified as one of the differentially expressed miRNAs in cluster 4 [PMC8235499]. In cell culture experiments, MIR320E was transfected into SNK6 cells and found to induce M2 polarization of THP-1 cells [PMC7761501]. The expression of MIR320E was measured using the 2−ΔCt method and normalized with the expression of miR-16 [PMC4647533]. In breast cancer, MIR320E has been found to be underexpressed in women who developed lymph node-positive tumors [PMC3706791]. Additionally, high expression levels of MIR320E have been associated with inferior prognosis in certain patient groups [PMC4342799]. In different cell types, such as HUVECs and HAECs, differential expression of pri-miRNAs was observed, including MIR320E for HAECs [PMC8216629]. Furthermore, MIR320E has been identified as one of the miRNAs that can target the PTEN pathway when analyzed using TargetScan [PMC8911495]. Finally, changes in plasmatic concentrations of MIR320E have been observed after stroke, with a decline in levels post-stroke [PMC7123062].